Regeneron Pharmaceuticals Currently Down Seven Consecutive Days, on Track for Longest Losing Streak Since October 2018 -- Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $792.61, down $1.09 or 0.14%

--Would be lowest close since Nov. 1, 2023, when it closed at $791.27

--Currently down eight of the past nine days

--Currently down seven consecutive days; down 4.78% over this period

--Longest losing streak since Oct. 26, 2018, when it fell for seven straight trading days

--Worst seven day stretch since the seven days ending Oct. 27, 2023, when it fell 6.16%

--Up 1.63% month-to-date

--Up 9.86% year-to-date

--Down 6.13% from its all-time closing high of $844.37 on Aug. 21, 2023

--Up 7.74% from 52 weeks ago (Nov. 16, 2022), when it closed at $735.67

--Down 6.13% from its 52-week closing high of $844.37 on Aug. 21, 2023

--Up 16.48% from its 52-week closing low of $680.49 on Jan. 9, 2023

--Traded as low as $784.96

--Down 1.1% at today's intraday low

--10th least active stock in the Nasdaq 100 today

All data as of 10:56:12 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 15, 2023 11:14 ET (16:14 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.